A primary defect in glucose production alone cannot induce glucose intolerance without defects in insulin secretion

Journal of Endocrinology

Volumn 210, Issue 3, 2011, Pages 335-347

  Mangiafico, Salvatore P ^a   Lim, Shueh H ^a   Neoh, Sandra ^a   Massinet, Helene ^a   Joannides, Christos N ^a   Proietto, Joseph ^a   Andrikopoulos, Sofianos ^a   Fam, Barbara C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE; TRANSGENIC RAT;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FEMALE; FRUCTOSE-BISPHOSPHATASE; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; GLUCOSE-6-PHOSPHATASE; INSULIN; INSULIN RESISTANCE; KIDNEY; LIVER; MALE; MODELS, BIOLOGICAL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RATS; RATS, TRANSGENIC; RNA, MESSENGER;

EID: 80052709666     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0126     Document Type: Article

References (50)

1. Andrikopoulos S & Proietto J 1995 The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 38 1389-1396.
2. Andrikopoulos S, Massa CM, Aston-Mourney K, Funkat A, Fam BC, Hull RL, Kahn SE & Proietto J 2005 Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. Journal of Endocrinology 187 45-53.
3. Andrikopoulos S, Blair AR, Deluca N, Fam BC & Proietto J 2008 Evaluating the glucose tolerance test in mice. American Journal of Physiology. Endocrinology and Metabolism 295 E1323-E1332.
4. Argaud D, Kirby TL, Newgard CB & Lange AJ 1997 Stimulation of glucose-6-phosphatase gene expression by glucose and fructose-2,6-bisphosphate. Journal of Biological Chemistry 272 12854-12861.
5. Arizmendi C, Liu S, Croniger C, Poli V & Friedman JE 1999 The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. Journal of Biological Chemistry 274 13033-13040.
6. Aston-Mourney K,Wong N, Kebede M, Zraika S, Balmer L, McMahon JM, Fam BC, Favaloro J, Proietto J, Morahan G et al. 2007 Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. Diabetologia 50 2476-2485.
7. Bock G, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Chandramouli V, Landau BR & Rizza RA 2007 Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes 56 1703-1711.
8. Boden G, Chen X & Stein TP 2001 Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. American Journal of Physiology. Endocrinology and Metabolism 280 E23-E30.
9. Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A & Del Prato S 1999 Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 48 99-105.
10. Buettner C, Patel R, Muse ED, Bhanot S, Monia BP, McKay R, Obici S & Rossetti L 2005 Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice. Journal of Clinical Investigation 115 1306-1313.
11. Calles-Escandon J & Robbins DC 1987 Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes 36 1167-1172.
12. Cersosimo E, Garlick P & Ferretti J 2000 Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes 49 1186-1193.
13. Chang AY & Schneider DI 1970 Abnormalities in hepatic enzyme activities during development of diabetes in db mice. Diabetologia 6 274-278.
14. Cherrington AD, Williams PE & Harris MS 1978 Relationship between the plasma glucose level and glucose uptake in the conscious dog. Metabolism 27 787-791.
15. Chevalier S, Burgess SC, Malloy CR, Gougeon R, Marliss EB & Morais JA 2006 The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 55 675-681.
16. Consoli A, Nurjhan N, Capani F & Gerich J 1989 Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38 550-557.
17. Fam BC, Morris MJ, Hansen MJ, Kebede M, Andrikopoulos S, Proietto J & Thorburn AW 2007 Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity. Diabetes, Obesity & Metabolism 9 840-852.
18. Fontes G, Zarrouki B, Hagman DK, Latour MG, Semache M, Roskens V, Moore PC, Prentki M, Rhodes CJ, Jetton TL et al. 2010 Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass. Diabetologia 53 2369-2379.
19. Funkat A, Massa CM, Jovanovska V, Proietto J & Andrikopoulos S 2004 Metabolic adaptations of three inbred strains of mice (C57BL/6, DBA/2, and 129T2) in response to a high-fat diet. Journal of Nutrition 134 3264-3269.
20. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR & Ferrannini E 2000 Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49 1367-1373.
21. Gerich JE 1997 Metabolic abnormalities in impaired glucose tolerance. Metabolism 46 40-43.
22. Gerich JE, Meyer C, Woerle HJ & Stumvoll M 2001 Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24 382-391.
23. Golay A, Swislocki AL, Chen YD & Reaven GM 1987 Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulindependent diabetic individuals. Metabolism 36 692-696.
24. Kebede M, Favaloro J, Gunton JE, Laybutt DR, Shaw M, Wong N, Fam BC, Aston-Mourney K, Rantzau C, Zulli A et al. 2008 Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. Diabetes 57 1887-1895.
25. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ & Storlien LH 1991 Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40 1397-1403.
26. Lamont BJ, Andrikopoulos S, Funkat A, Favaloro J, Ye JM, Kraegen EW, Howlett KF, Zajac JD & Proietto J 2003 Peripheral insulin resistance develops in transgenic rats overexpressing phosphoenolpyruvate carboxykinase in the kidney. Diabetologia 46 1338-1347.
27. Lamont BJ, Visinoni S, Fam BC, Kebede M, Weinrich B, Papapostolou S, Massinet H, Proietto J, Favaloro J & Andrikopoulos S 2006 Expression of human fructose-1,6-bisphosphatase in the liver of transgenic mice results in increased glycerol gluconeogenesis. Endocrinology 147 2764-2772.
28. Levine R & Fritz IB 1956 The relation of insulin to liver metabolism. Diabetes 5 209-219 (discussion, 219-222).
29. Lewis GF, Zinman B, Groenewoud Y, Vranic M & Giacca A 1996 Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45 454-462.
30. Massillon D, Barzilai N, Chen W, Hu M & Rossetti L 1996 Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. Journal of Biological Chemistry 271 9871-9874.
31. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J & Gerich J 1992 Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. New England Journal of Medicine 326 22-29.
32. Mittelman SD, Fu YY, Rebrin K, Steil G & Bergman RN 1997 Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. Journal of Clinical Investigation 100 3121-3130.
33. Nolan CJ & Proietto J 1994 The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia 37 976-984.
34. Nurjhan N, Consoli A & Gerich J 1992 Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 89 169-175.
35. Obici S, Zhang BB, Karkanias G & Rossetti L 2002 Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Medicine 8 1376-1382.
36. Perriello G, Pampanelli S, Del Sindaco P, Lalli C, Ciofetta M, Volpi E, Santeusanio F, Brunetti P & Bolli GB 1997 Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes 46 1010-1016.
37. Proietto J & Andrikopoulos S 2004 Molecular mechanisms of increased glucose production: identifying potential therapeutic targets. Journal of Investigative Medicine 52 389-393.
38. Randeree HA, Omar MA, Motala AA & Seedat MA 1992 Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 15 1258-1263.
39. Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhausl W & Shulman GI 2000 Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49 701-707.
40. Rosella G, Zajac JD, Kaczmarczyk SJ, Andrikopoulos S & Proietto J 1993 Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene. Molecular Endocrinology 7 1456-1462.
41. Rosella G, Zajac JD, Baker L, Kaczmarczyk SJ, Andrikopoulos S, Adams TE & Proietto J 1995 Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive phosphoenolpyruvate carboxykinase gene. Molecular Endocrinology 9 1396-1404.
42. Seidman I, Horland AA & Teebor GW 1970 Glycolytic and gluconeogenic enzyme activities in the hereditary obese-hyperglycemic syndrome and in acquired obesity. Diabetologia 6 313-316.
43. Song S, Andrikopoulos S, Filippis C, Thorburn AW, Khan D & Proietto J 2001 Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin. American Journal of Physiology. Endocrinology and Metabolism 281 E275-E282.
44. Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S & Gerich J 1998 Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. American Journal of Physiology 274 E817-E826.
45. Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS & Friedman JE 2002 Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. Journal of Biological Chemistry 277 23301-23307.
46. Thorburn AW, Gumbiner B, Brechtel G & Henry RR 1990 Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects. Diabetes 39 22-30.
47. Trinh KY, O'Doherty RM, Anderson P, Lange AJ & Newgard CB 1998 Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. Journal of Biological Chemistry 273 31615-31620.
48. Valera A, Pujol A, Pelegrin M & Bosch F 1994 Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulindependent diabetes mellitus. PNAS 91 9151-9154.
49. Visinoni S, Fam BC, Blair A, Rantzau C, Lamont BJ, Bouwman R,Watt MJ, Proietto J, Favaloro JM & Andrikopoulos S 2008 Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver. American Journal of Physiology. Endocrinology and Metabolism 295 E1132-E1141.
50. Wencel HE, Smothers C, Opara EC, Kuhn CM, Feinglos MN & Surwit RS 1995 Impaired second phase insulin response of diabetes-prone C57BL/6J mouse islets. Physiology & Behavior 57 1215-1220.